Literature DB >> 15185857

Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis.

Thorsten Vowinkel1, Theodore J Kalogeris, Mikiji Mori, Christian F Krieglstein, D Neil Granger.   

Abstract

In dextran sulfate sodium (DSS)-induced inflammatory bowel disease in mice the relationship between the amount of ingested DSS and the severity of colitis has not been systematically investigated. We examined whether (1) the severity of colitis is DSS load-dependent, and (2) there is a critical DSS load required to reliably induce colitis. DSS load was calculated as: (drinking volume (ml) x [DSS (g)/100 ml])/body weight (g). A minimum DSS load > or = 30 mg/g body weight over 7 days resulted in a significantly elevated colonic myeloperoxidase (MPO) activity, compared to mice receiving less DSS and controls (P < 0.05). Histomorphologic data correlated with MPO activity and revealed significantly higher damage scores once the DSS load was > or = 30 mg/g body weight. Our findings demonstrate the importance of monitoring DSS load in this model of experimental colitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185857     DOI: 10.1023/b:ddas.0000026298.72088.f7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  Role of endotoxin in intestinal reperfusion-induced expression of E-selectin.

Authors:  P Bauer; J M Russell; D N Granger
Journal:  Am J Physiol       Date:  1999-02

2.  Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice.

Authors:  Hisashi Iizasa; Naomi Genda; Tomohide Kitano; Mikio Tomita; Kazuyo Nishihara; Masahiro Hayashi; Kayako Nakamura; Shizuko Kobayashi; Emi Nakashima
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

3.  Glucocorticoids potentiate the dipsogenic action of angiotensin II.

Authors:  R Ganesan; C Sumners
Journal:  Brain Res       Date:  1989-10-09       Impact factor: 3.252

4.  The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.

Authors:  Makoto Sasaki; Sulaiman Bharwani; Paul Jordan; Takashi Joh; Kenneth Manas; April Warren; Hirohisa Harada; Patsy Carter; John W Elrod; Michael Wolcott; Matthew B Grisham; J Steven Alexander
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

5.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

6.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

7.  Antidipsogenic effect of endotoxin in the rat.

Authors:  A Focà; P Nicoletta; G Matera; P Mastroeni; A P Caputi
Journal:  Circ Shock       Date:  1983

8.  A novel human fibroblast growth factor treats experimental intestinal inflammation.

Authors:  Michael Jeffers; William F McDonald; Rajeev A Chillakuru; Meijia Yang; Hiroshi Nakase; Lisa L Deegler; Elizabeth D Sylander; Beth Rittman; Alison Bendele; R Balfour Sartor; Henri S Lichenstein
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

9.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

10.  Effect of prostaglandin E1 and its biosynthesis inhibitor indomethacin on drinking in the rat.

Authors:  M F Pérez Guaita; E Chiaraviglio
Journal:  Pharmacol Biochem Behav       Date:  1980-12       Impact factor: 3.533

View more
  53 in total

1.  Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.

Authors:  Suzanne M Abimosleh; Ruth J Lindsay; Ross N Butler; Adrian G Cummins; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Interleukin-1beta mediates the extra-intestinal thrombosis associated with experimental colitis.

Authors:  Hideo Yoshida; Janice Russell; Elena Y Senchenkova; Lidiana D Almeida Paula; D Neil Granger
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  Angiogenesis blockade as a new therapeutic approach to experimental colitis.

Authors:  Silvio Danese; Miquel Sans; David M Spencer; Ivy Beck; Fernando Doñate; Marian L Plunkett; Carol de la Motte; Raymond Redline; David E Shaw; Alan D Levine; Andrew P Mazar; Claudio Fiocchi
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 4.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

5.  Role of tumor necrosis factor-α in the extraintestinal thrombosis associated with colonic inflammation.

Authors:  Hideo Yoshida; Cigdem Erkuran Yilmaz; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2010-12-16       Impact factor: 5.325

6.  Impaired enterocyte proliferation in aquaporin-3 deficiency in mouse models of colitis.

Authors:  Jay R Thiagarajah; Dan Zhao; A S Verkman
Journal:  Gut       Date:  2007-06-15       Impact factor: 23.059

7.  Chemically induced mouse models of acute and chronic intestinal inflammation.

Authors:  Stefan Wirtz; Vanessa Popp; Markus Kindermann; Katharina Gerlach; Benno Weigmann; Stefan Fichtner-Feigl; Markus F Neurath
Journal:  Nat Protoc       Date:  2017-06-01       Impact factor: 13.491

8.  Apolipoprotein A-IV inhibits experimental colitis.

Authors:  Thorsten Vowinkel; Mikiji Mori; Christian F Krieglstein; Janice Russell; Fumito Saijo; Sulaiman Bharwani; Richard H Turnage; W Sean Davidson; Patrick Tso; D Neil Granger; Theodore J Kalogeris
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Authors:  Benoit Foligné; Sophie Nutten; Lothar Steidler; Véronique Dennin; Denise Goudercourt; Annick Mercenier; Bruno Pot
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

10.  Absence of stearoyl-CoA desaturase-1 does not promote DSS-induced acute colitis.

Authors:  Marcia L E Macdonald; Nagat Bissada; Bruce A Vallance; Michael R Hayden
Journal:  Biochim Biophys Acta       Date:  2009-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.